𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C

✍ Scribed by Ponziani, Francesca Romana; Viganò, Raffaella; Iemmolo, Rosa Maria; Donato, Maria Francesca; Rendina, Maria; Toniutto, Pierluigi; Pasulo, Luisa; Morelli, Maria Cristina; Burra, Patrizia; Miglioresi, Lucia; Merli, Manuela; Di Paolo, Daniele; Fagiuoli, Stefano; Gasbarrini, Antonio; Pompili, Maurizio; Belli, L.; Gerunda, G.E.; Marino, M.; Montalti, R.; Di Benedetto, F.; De Ruvo, N.; Rigamonti, C.; Colombo, M.; Rossi, G.; Di Leo, A.; Lupo, L.; Memeo, V.; Bringiotti, R.; Zappimbulso, M.; Bitetto, D.; Vero, V.; Colpani, M.; Fornasiere, E.; Pinna, A.D.; Morelli, M.C.; Bertuzzo, V.; De Martin, E.; Senzolo, M.; Ettorre, G.M.; Visco-Comandini, U.; Antonucci, G.; Angelico, M.; Tisone, G.; Giannelli, V.; Giusto, M.

Book ID
123375474
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
521 KB
Volume
46
Category
Article
ISSN
1590-8658

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictors of sustained virological resp
Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation
✍ Matteo Cescon; Gian Luca Grazi; Alessandro Cucchetti; Gaetano Vetrone; Matteo Ra 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

Factors associated with sustained virological response (SVR) in patients treated for hepatitis C virus (HCV) recurrence after liver transplantation (LT) are unclear. Ninety-nine HCV-positive/hepatitis B surface antigen-negative patients received antiviral treatment (AVT) with interferon/peginterfero

Sustained viral response to interferon a
Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C
✍ Manal F. Abdelmalek; Roberto J. Firpi; Consuelo Soldevila-Pico; Alan I. Reed; Al 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB 👁 1 views

Recurrent hepatitis C infection is an important cause of progressive fibrosis, cirrhosis, and graft loss following orthotopic liver transplantation. Treatment for posttransplant recurrence of hepatitis C with interferon-based therapy is difficult but results in loss of detectable virus in up to 30%